Matthieu Lafaurie, Claire Montlahuc, Solen Kerneis, Victoire de Lastours, Sophie Abgrall, Véronique Manceron, Carine Couzigou, Amélie Chabrol, Axelle de Raigniac, Xavier Lescure, Pascale Longuet, Philippe Lesprit, Dominique Vanjak, Raphael Lepeule
OBJECTIVES: Data on the efficacy of vancomycin catheter lock therapy (VLT) for conservative treatment of totally implantable venous access port-related infections (TIVAP-RI) due to CoNS are scarce. The aim of this study was to evaluate the effectiveness of VLT in the treatment of TIVAP-RI due to CoNS in cancer patients. METHODS: This prospective, observational, multicentre study included adults with cancer treated with VLT for a TIVAP-RI due to CoNS. The primary endpoint was the success of VLT, defined as no TIVAP removal nor TIVAP-RI recurrence within 3 months after initiation of VLT...
May 3, 2023: Journal of Antimicrobial Chemotherapy